Golden
Vincere Biosciences

Vincere Biosciences

Vincere Biosciences is a company developing drugs to fight Parkinson’s disease and other age-related disorders.

Vincere Biosciences is a company developing drugs that can restore mitochondrial quality to slow the progression of Parkinson’s disease and other age-related disorders where deficits in mitochondrial health is known to underlie the disease process.

There is no greater need in the world than extending human healthspan and as the human population ages, age-related diseases will become an unsustainable problem for humanity. Every member of the team is passionate about this cause, bringing decades of biology, technology, and drug discovery expertise to the fight. -- Spring Behrouz, PhD - CEO



Timeline

May 2019

Michael J Fox Foundation funds $1 million milestone-based project "Discovery and Development of Parkin Activators as Therapies for Parkinson's Disease"

October 16, 2018

Dr. Kalpana Merchant, PhD, former Chief Scientific Officer of Tailored Neuroscience Therapeutics at Eli Lilly, joins Vincere Biosciences as Chief Scientific Officer to develop novel therapeutics targeting mitochondrial qualitity control.

October 2018

Vincere Biosciences launched by NeuroInitiative to develop small molecules for Parkinson's Disease

People

Name
Role
LinkedIn

Andy Lee

COO



Bahareh (Spring) Behrouz

CEO



Jim Liang

Board Member & Investor



Kalpana Merchant

CSO



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References